Oxford Biomedica PLC — Director's Dealing 2017

Jul 14, 2017

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1574L

Oxford Biomedica PLC

14 July 2017

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

1	Issuer	Oxford BioMedica PLC
2	Reason for notification	Notification relates to DTR 3.1.2R
3	Name of PDMR	Martin Diggle
4	Connected person	Notification relates to following connected persons: Vulpes Testudo Fund
5	Notification in respect of	Notification in respect of holdings of persons in 4 above
6	Description of shares	Oxford BioMedica PLC ordinary shares of 1p each
7	Name of registered shareholders and number of shares	Vulpes Life Sciences Fund - 549,932,000 shares Vulpes Testudo Fund - 33,333,333 shares
8	Nature of transaction	Acquisition and Disposal
9	Number of shares acquired	Vulpes Testudo Fund - 660,000 shares
10	Percentage of issued class acquired	Vulpes Testudo Fund- 0.02%
11	Shares disposed	Vulpes Testudo Fund - 658,899
12	Percentage of issued class disposed	Vulpes Testudo Fund - 0.02%
13/14	Price per share of transactions, and date	Vulpes Testudo Fund Sold     658,899 shares @ £0.1003, 13 Jan 2017 Bought 660,000 shares @ £0.089,   13 Jan 2017
15	Total holding following notification and total percentage holding following notification	Vulpes Life Sciences Fund - 549,932,000 shares 17.8% Vulpes Testudo Fund - 33,334,434 shares 1.1%
16	Date issuer informed	14 July 2017
23	Any additional information	None
24	Contact name and telephone number	T. Watts, Chief Financial Officer Oxford BioMedica +44 (0)1865 783000

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHKMGMNFDVGNZM